Zobrazeno 1 - 10
of 717
pro vyhledávání: '"Ad, Ho"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Tinguely, S Vallet, B Jenni, M Witzens-Harig, G Mechtersheimer, AD Ho, H Goldschmidt, D Jäger, M Boccadoro, M Ladetto
Publikováno v:
Swiss Medical Weekly, Vol 136, Iss 2526 (2006)
Externí odkaz:
https://doaj.org/article/aa84930d98f848acafeaf0c128ff4e09
Publikováno v:
Blood. 84:3550-3557
Mononuclear cell preparations from peripheral blood after mobilization with hematopoietic growth factors have been shown to induce accelerated neutrophil and platelet recovery as compared with that induced by autologous bone marrow transplantation af
Autor:
Schetelig J, Christian Thiede, Bornhäuser M, Schwerdtfeger R, Kiehl M, Beyer J, Kröger N, Hensel M, Scheffold C, Ad, Ho, Kienast J, Neubauer A, Ar, Zander, Aa, Fauser, Ehninger G, Siegert W
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
We studied in 30 patients with progressive or relapsing chronic lymphocytic leukemia (CLL) if hematopoietic stem cell transplantation (HSCT) after conditioning with fludarabine, busulfan and ATG is effective and if treatment related mortality can be
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 23(10)
The influence of the mimic hematopoietic microenvironment and adhesion factor on the initial divisional behavior of human cord blood hematopoietic progenitors was studied in the culture system with certain cytokines.(1) CD(34)(+) CD(38)(-) single cel
Publikováno v:
Bone Marrow Transplantation. 23:S10-S11
Publikováno v:
Blood. 67:529-532
A patient with Burkitt's lymphoma in complete remission received myeloablative consolidation treatment with superfractionated total body irradation (1,320 rad) and cyclophosphamide (200 mg/kg) followed by autologous transplantation of previously harv
Autor:
Ad, Ho, Wolfgang Wagner
Publikováno v:
Europe PubMed Central
Mounting evidence indicates that human cancers may originate from malignant transformation of stem cells. The most convincing proof is found in acute myeloid leukemia, where only a small subset of slowly dividing cells was able to induce transplantab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e1a27c8ed739138e8e0c3234a2a33dc5
http://europepmc.org/abstract/med/17939299
http://europepmc.org/abstract/med/17939299
Autor:
Derigs P; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany. Patrick.Derigs@med.uni-heidelberg.de., Schubert ML; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Dreger P; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Schmitt A; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Yousefian S; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany., Haas S; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK., Röthemeier C; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany., Neuber B; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Hückelhoven-Krauss A; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Brüggemann M; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Bernhard H; Department of Internal Medicine V, Klinikum Darmstadt, Darmstadt, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Lindemann A; Onkologie in Ettlingen, Ettlingen, Germany., Rummel M; Department of Internal Medicine IV, University Hospital Giessen, Giessen, Germany., Michels B; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Korell F; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Ho AD; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany., Müller-Tidow C; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany., Schmitt M; Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Publikováno v:
Leukemia [Leukemia] 2024 Nov; Vol. 38 (11), pp. 2419-2428. Date of Electronic Publication: 2024 Aug 27.
Autor:
Linke P; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany., Munding N; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany., Kimmle E; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany., Kaufmann S; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany., Hayashi K; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan., Nakahata M; Department of Macromolecular Science, Graduate School of Science, Osaka University, Osaka, 560-0043, Japan., Takashima Y; Department of Macromolecular Science, Graduate School of Science, Osaka University, Osaka, 560-0043, Japan., Sano M; Institute of Natural Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China., Bastmeyer M; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan.; Cell and Neurobiology, Zoological Institute, Karlsruhe Institute of Technology, 76131, Karlsruhe, Germany.; Institute for Biological and Chemical Systems - Biological Information Processing (IBCS-BIP), Karlsruhe Institute of Technology, 76334, Eggenstein-Leopoldshafen, Germany., Holstein T; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan.; Molecular Genetics and Evolution, Centre for Organismal Studies, Heidelberg University, 69221, Heidelberg, Germany., Dietrich S; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany.; Department of Haematology, Oncology, and Clinical Immunology, Universitätsklinikum Düsseldorf, 40225, Düsseldorf, Germany., Müller-Tidow C; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Harada A; The Institute of Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibaraki, Osaka, 567-0047, Japan., Ho AD; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan.; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany.; Molecular Medicine Partnership Unit Heidelberg, EMBL and Heidelberg University, 69120, Heidelberg, Germany., Tanaka M; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, 69120, Heidelberg, Germany.; Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, 606-8501, Japan.
Publikováno v:
Advanced healthcare materials [Adv Healthc Mater] 2024 Apr; Vol. 13 (10), pp. e2302607. Date of Electronic Publication: 2023 Dec 25.